SCHEMBL3592420

SCHEMBL3592420

CC(N)(C=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11518474 1.00
SCHEMBL7202469 1.00
SCHEMBL5165968 0.77
SCHEMBL5165964 0.77
SCHEMBL6765110 0.77
SCHEMBL23027300 0.77
Pivalate SCHEMBL28262239 0.76 ALDH1A1 (0.50)
Tert-Butylamine SCHEMBL14836204 0.75 ALDH1A1 (0.47)
Tert-Butylamine SCHEMBL362032 0.75
Hydrochloric Acid SCHEMBL5166065 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115876897-A Method for simultaneously detecting multiple limited perfumes in cosmetics 汕头海关技术中心 2023-03-31 CN claimed
US-20130210769-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2013-08-15 US claimed
US-8431607-B2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY (BM) 2013-04-30 US claimed
US-20100234365-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2010-09-16 US claimed
EP-2121598-A2 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2009-11-25 EP claimed
WO-2008076754-A2 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2008-06-26 WO claimed
CN-117099796-B Continuous mosquito coil 大日本除虫菊株式会社 2026-05-12 CN disclosed
US-12479108-B2 Device and control method using machine learning for a robot to perform an insertion task ROBERT BOSCH GMBH (DE) 2025-11-25 US disclosed
CN-120076993-A Aerosol dispenser and nozzle 宝洁公司 2025-05-30 CN disclosed
US-20250064933-A1 CHIMERIC ANTIGEN RECEPTORS COMPRISING A PDZ BINDING MOTIF ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) 2025-02-27 US disclosed
CN-114437868-B Jasmine fragrance compound and gardenia fragrance type fragrance 东莞波顿香料有限公司 2024-01-12 CN disclosed
CN-114874061-B Preparation method of prasugrel intermediate and analogues thereof 中国人民解放军海军军医大学 2023-12-22 CN disclosed
WO-2023098699-A1 COMPOUNDS AND THEIR USES AS CD38 INHIBITORS NANJING IMMUNOPHAGE BIOTECH CO., LTD (CN) 2023-06-08 WO disclosed
CN-100374420-C indole amide derivatives having glycogen phosphorylase inhibitory activity ASTRAZENECA AB CO LTD (SE) 2008-03-12 CN disclosed
US-7138415-B2 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity ASTRAZENECA AB (SE) 2006-11-21 US disclosed
CN-1639120-A Indolamid derivatives which possess glycogenphosphorylase inhibitory activity ASTRAZENECA AB (SE) 2005-07-13 CN disclosed
US-20050107362-A1 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity ASTRA ZENECA AB (SE) 2005-05-19 US disclosed
EP-1483240-A1 INDOLAMID DERIVATIVES WHICH POSSESS GLYCOGEN PHOSPHORYLASE INHIBITORY ACTIVITY AstraZeneca AB (SE) 2004-12-08 EP disclosed
WO-2003074484-A1 INDOLAMID DERIVATIVES WHICH POSSESS GLYCOGENPHOSPHORYLASE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2003-09-12 WO disclosed
CN-1288467-A Compounds with growth hormone releasing properties NOVO NORDISK AS (DK) 2001-03-21 CN disclosed